continuous improvement – Page 38

RMG torque instability during wet granulation – GMP-compliant optimization approach

Addressing RMG Torque Instability in Wet Granulation for GMP Compliance In pharmaceutical manufacturing, particularly during the wet granulation process, issues such as RMG (Rapid Mixer Granulator) torque instability can severely…

Granule friability issue post-technology transfer – process robustness improvement plan

Addressing Granule Friability After Technology Transfer: Enhancing Process Robustness Granule friability issues frequently emerge during or after the technological transfer of a pharmaceutical product. This situation can significantly hinder product…

FBD drying inefficiency during CPV trending – inspection-ready justification

“`html Addressing FBD Drying Inefficiency: A Practical Approach for CPV Trending In the world of pharmaceutical manufacturing, achieving efficiency during drying processes, particularly in Fluid Bed Drying (FBD), is critical.…

Granule friability issue during wet granulation – inspection-ready justification

Resolving Granule Friability Challenges during Wet Granulation for Inspection-Ready Compliance In pharmaceutical manufacturing, granule friability can hinder the effectiveness and efficiency of the wet granulation process, ultimately impacting product quality…

Non-uniform granule size during wet granulation – GMP-compliant optimization approach

Addressing Challenges of Non-uniform Granule Size in Wet Granulation for GMP Compliance Non-uniform granule size during wet granulation can significantly impact product quality, efficacy, and consistency—key concerns in pharmaceutical manufacturing.…

End-point detection failure during scale-up – inspection-ready justification

Addressing End-point Detection Failures During Scale-up: An Inspection-Ready Guide End-point detection failures during the scale-up phase present significant challenges in pharmaceutical manufacturing, particularly in granulation processes. These failures can lead…

End-point detection failure during scale-up – GMP-compliant optimization approach

“`html Addressing Failures in End-Point Detection During Scale-Up for Enhanced GMP Compliance In the pharmaceutical manufacturing sector, successful scale-up from laboratory to production levels is critical to meet demand while…

FBD drying inefficiency during wet granulation – inspection-ready justification

Addressing Inefficiencies in FBD Drying During Wet Granulation Processes Filtration and Blending Drying (FBD) inefficiencies during wet granulation can significantly compromise product quality, process yield, and operational efficiency. This article…

Over-wetting risk during validation – inspection-ready justification

Managing Over-Wetting Risks During Validation for Optimal Pharmaceutical Manufacturing In the pharmaceutical industry, the granular adjustment of moisture levels during the validation of granulation processes is critical for achieving optimal…

Granule friability issue during scale-up – inspection-ready justification

Addressing Granule Friability During Scale-Up: Inspection-Ready Solutions Granule friability during scale-up can pose significant risks to product quality and process efficiency in the pharmaceutical manufacturing sector. As organizations aim for…

Over-wetting risk during wet granulation – GMP-compliant optimization approach

Mitigating Over-wetting Risk in Wet Granulation: A Comprehensive GMP Framework The wet granulation process is a critical step in pharmaceutical manufacturing that enhances the flow and compaction characteristics of powder…

FBD drying inefficiency during scale-up – process robustness improvement plan

Enhancing Process Robustness to Address FBD Drying Inefficiency During Scale-Up In the realm of pharmaceutical manufacturing, fluidized bed drying (FBD) is a critical process that can dictate the quality and…